Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study.
Identifieur interne : 002704 ( Main/Exploration ); précédent : 002703; suivant : 002705Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study.
Auteurs : Paul Mitchell [Australie] ; Pascale Massin [France] ; Susan Bressler [États-Unis] ; Cheryl D. Coon [États-Unis] ; Jennifer Petrillo [Suisse] ; Alberto Ferreira [Suisse] ; Neil M. Bressler [États-Unis]Source :
- Current medical research and opinion [ 1473-4877 ] ; 2015.
Descripteurs français
- KwdFr :
- Acuité visuelle, Adulte d'âge moyen, Association thérapeutique, Enquêtes et questionnaires, Femelle, Humains, Inhibiteurs de l'angiogenèse (administration et posologie), Inhibiteurs de l'angiogenèse (usage thérapeutique), Mâle, Oedème maculaire (traitement médicamenteux), Ranibizumab (administration et posologie), Rétinopathie diabétique (traitement médicamenteux), Sujet âgé.
- MESH :
- administration et posologie : Inhibiteurs de l'angiogenèse, Ranibizumab.
- traitement médicamenteux : Oedème maculaire, Rétinopathie diabétique.
- usage thérapeutique : Inhibiteurs de l'angiogenèse.
- Acuité visuelle, Adulte d'âge moyen, Association thérapeutique, Enquêtes et questionnaires, Femelle, Humains, Mâle, Sujet âgé.
English descriptors
- KwdEn :
- Aged, Angiogenesis Inhibitors (administration & dosage), Angiogenesis Inhibitors (therapeutic use), Combined Modality Therapy, Diabetic Retinopathy (drug therapy), Female, Humans, Macular Edema (drug therapy), Male, Middle Aged, Ranibizumab (administration & dosage), Surveys and Questionnaires, Visual Acuity.
- MESH :
- chemical , administration & dosage : Angiogenesis Inhibitors, Ranibizumab.
- chemical , therapeutic use : Angiogenesis Inhibitors.
- drug therapy : Diabetic Retinopathy, Macular Edema.
- Aged, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, Visual Acuity.
Abstract
To determine the impact of ranibizumab 0.5 mg on patient-reported visual function over 36 months in individuals with visual impairment from diabetic macular edema.
DOI: 10.1185/03007995.2015.1081880
PubMed: 26327116
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002791
- to stream PubMed, to step Curation: 002722
- to stream PubMed, to step Checkpoint: 002722
- to stream Ncbi, to step Merge: 002A08
- to stream Ncbi, to step Curation: 002A08
- to stream Ncbi, to step Checkpoint: 002A08
- to stream Main, to step Merge: 002704
- to stream Main, to step Curation: 002704
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study.</title><author><name sortKey="Mitchell, Paul" sort="Mitchell, Paul" uniqKey="Mitchell P" first="Paul" last="Mitchell">Paul Mitchell</name><affiliation wicri:level="1"><nlm:affiliation>a a Department of Ophthalmology and Westmead Millennium Institute , University of Sydney , Sydney , Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>a a Department of Ophthalmology and Westmead Millennium Institute , University of Sydney , Sydney </wicri:regionArea><wicri:noRegion>Sydney </wicri:noRegion></affiliation></author><author><name sortKey="Massin, Pascale" sort="Massin, Pascale" uniqKey="Massin P" first="Pascale" last="Massin">Pascale Massin</name><affiliation wicri:level="1"><nlm:affiliation>b b Service d'Ophtalmologie, Hôpital Lariboisière APHP, Université Paris Diderot , Paris , France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>b b Service d'Ophtalmologie, Hôpital Lariboisière APHP, Université Paris Diderot , Paris </wicri:regionArea><wicri:noRegion>Paris </wicri:noRegion><wicri:noRegion>Paris </wicri:noRegion></affiliation></author><author><name sortKey="Bressler, Susan" sort="Bressler, Susan" uniqKey="Bressler S" first="Susan" last="Bressler">Susan Bressler</name><affiliation wicri:level="2"><nlm:affiliation>c c Retina Division , Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , MD , USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>c c Retina Division , Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , MD </wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Coon, Cheryl D" sort="Coon, Cheryl D" uniqKey="Coon C" first="Cheryl D" last="Coon">Cheryl D. Coon</name><affiliation wicri:level="2"><nlm:affiliation>d d Outcometrix , Tucson , AZ , USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>d d Outcometrix , Tucson , AZ </wicri:regionArea><placeName><region type="state">Arizona</region></placeName></affiliation></author><author><name sortKey="Petrillo, Jennifer" sort="Petrillo, Jennifer" uniqKey="Petrillo J" first="Jennifer" last="Petrillo">Jennifer Petrillo</name><affiliation wicri:level="1"><nlm:affiliation>e e Novartis Pharma AG , Basel , Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>e e Novartis Pharma AG , Basel </wicri:regionArea><wicri:noRegion>Basel </wicri:noRegion></affiliation></author><author><name sortKey="Ferreira, Alberto" sort="Ferreira, Alberto" uniqKey="Ferreira A" first="Alberto" last="Ferreira">Alberto Ferreira</name><affiliation wicri:level="1"><nlm:affiliation>e e Novartis Pharma AG , Basel , Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>e e Novartis Pharma AG , Basel </wicri:regionArea><wicri:noRegion>Basel </wicri:noRegion></affiliation></author><author><name sortKey="Bressler, Neil M" sort="Bressler, Neil M" uniqKey="Bressler N" first="Neil M" last="Bressler">Neil M. Bressler</name><affiliation wicri:level="2"><nlm:affiliation>c c Retina Division , Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , MD , USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>c c Retina Division , Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , MD </wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26327116</idno><idno type="pmid">26327116</idno><idno type="doi">10.1185/03007995.2015.1081880</idno><idno type="wicri:Area/PubMed/Corpus">002791</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002791</idno><idno type="wicri:Area/PubMed/Curation">002722</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002722</idno><idno type="wicri:Area/PubMed/Checkpoint">002722</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002722</idno><idno type="wicri:Area/Ncbi/Merge">002A08</idno><idno type="wicri:Area/Ncbi/Curation">002A08</idno><idno type="wicri:Area/Ncbi/Checkpoint">002A08</idno><idno type="wicri:Area/Main/Merge">002704</idno><idno type="wicri:Area/Main/Curation">002704</idno><idno type="wicri:Area/Main/Exploration">002704</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study.</title><author><name sortKey="Mitchell, Paul" sort="Mitchell, Paul" uniqKey="Mitchell P" first="Paul" last="Mitchell">Paul Mitchell</name><affiliation wicri:level="1"><nlm:affiliation>a a Department of Ophthalmology and Westmead Millennium Institute , University of Sydney , Sydney , Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>a a Department of Ophthalmology and Westmead Millennium Institute , University of Sydney , Sydney </wicri:regionArea><wicri:noRegion>Sydney </wicri:noRegion></affiliation></author><author><name sortKey="Massin, Pascale" sort="Massin, Pascale" uniqKey="Massin P" first="Pascale" last="Massin">Pascale Massin</name><affiliation wicri:level="1"><nlm:affiliation>b b Service d'Ophtalmologie, Hôpital Lariboisière APHP, Université Paris Diderot , Paris , France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>b b Service d'Ophtalmologie, Hôpital Lariboisière APHP, Université Paris Diderot , Paris </wicri:regionArea><wicri:noRegion>Paris </wicri:noRegion><wicri:noRegion>Paris </wicri:noRegion></affiliation></author><author><name sortKey="Bressler, Susan" sort="Bressler, Susan" uniqKey="Bressler S" first="Susan" last="Bressler">Susan Bressler</name><affiliation wicri:level="2"><nlm:affiliation>c c Retina Division , Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , MD , USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>c c Retina Division , Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , MD </wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Coon, Cheryl D" sort="Coon, Cheryl D" uniqKey="Coon C" first="Cheryl D" last="Coon">Cheryl D. Coon</name><affiliation wicri:level="2"><nlm:affiliation>d d Outcometrix , Tucson , AZ , USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>d d Outcometrix , Tucson , AZ </wicri:regionArea><placeName><region type="state">Arizona</region></placeName></affiliation></author><author><name sortKey="Petrillo, Jennifer" sort="Petrillo, Jennifer" uniqKey="Petrillo J" first="Jennifer" last="Petrillo">Jennifer Petrillo</name><affiliation wicri:level="1"><nlm:affiliation>e e Novartis Pharma AG , Basel , Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>e e Novartis Pharma AG , Basel </wicri:regionArea><wicri:noRegion>Basel </wicri:noRegion></affiliation></author><author><name sortKey="Ferreira, Alberto" sort="Ferreira, Alberto" uniqKey="Ferreira A" first="Alberto" last="Ferreira">Alberto Ferreira</name><affiliation wicri:level="1"><nlm:affiliation>e e Novartis Pharma AG , Basel , Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>e e Novartis Pharma AG , Basel </wicri:regionArea><wicri:noRegion>Basel </wicri:noRegion></affiliation></author><author><name sortKey="Bressler, Neil M" sort="Bressler, Neil M" uniqKey="Bressler N" first="Neil M" last="Bressler">Neil M. Bressler</name><affiliation wicri:level="2"><nlm:affiliation>c c Retina Division , Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , MD , USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>c c Retina Division , Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , MD </wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author></analytic><series><title level="j">Current medical research and opinion</title><idno type="eISSN">1473-4877</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Angiogenesis Inhibitors (administration & dosage)</term><term>Angiogenesis Inhibitors (therapeutic use)</term><term>Combined Modality Therapy</term><term>Diabetic Retinopathy (drug therapy)</term><term>Female</term><term>Humans</term><term>Macular Edema (drug therapy)</term><term>Male</term><term>Middle Aged</term><term>Ranibizumab (administration & dosage)</term><term>Surveys and Questionnaires</term><term>Visual Acuity</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acuité visuelle</term><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Inhibiteurs de l'angiogenèse (administration et posologie)</term><term>Inhibiteurs de l'angiogenèse (usage thérapeutique)</term><term>Mâle</term><term>Oedème maculaire (traitement médicamenteux)</term><term>Ranibizumab (administration et posologie)</term><term>Rétinopathie diabétique (traitement médicamenteux)</term><term>Sujet âgé</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Angiogenesis Inhibitors</term><term>Ranibizumab</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Angiogenesis Inhibitors</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Inhibiteurs de l'angiogenèse</term><term>Ranibizumab</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Diabetic Retinopathy</term><term>Macular Edema</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Oedème maculaire</term><term>Rétinopathie diabétique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Inhibiteurs de l'angiogenèse</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Combined Modality Therapy</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Surveys and Questionnaires</term><term>Visual Acuity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Acuité visuelle</term><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To determine the impact of ranibizumab 0.5 mg on patient-reported visual function over 36 months in individuals with visual impairment from diabetic macular edema.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li><li>Suisse</li><li>États-Unis</li></country><region><li>Arizona</li><li>Maryland</li></region></list><tree><country name="Australie"><noRegion><name sortKey="Mitchell, Paul" sort="Mitchell, Paul" uniqKey="Mitchell P" first="Paul" last="Mitchell">Paul Mitchell</name></noRegion></country><country name="France"><noRegion><name sortKey="Massin, Pascale" sort="Massin, Pascale" uniqKey="Massin P" first="Pascale" last="Massin">Pascale Massin</name></noRegion></country><country name="États-Unis"><region name="Maryland"><name sortKey="Bressler, Susan" sort="Bressler, Susan" uniqKey="Bressler S" first="Susan" last="Bressler">Susan Bressler</name></region><name sortKey="Bressler, Neil M" sort="Bressler, Neil M" uniqKey="Bressler N" first="Neil M" last="Bressler">Neil M. Bressler</name><name sortKey="Coon, Cheryl D" sort="Coon, Cheryl D" uniqKey="Coon C" first="Cheryl D" last="Coon">Cheryl D. Coon</name></country><country name="Suisse"><noRegion><name sortKey="Petrillo, Jennifer" sort="Petrillo, Jennifer" uniqKey="Petrillo J" first="Jennifer" last="Petrillo">Jennifer Petrillo</name></noRegion><name sortKey="Ferreira, Alberto" sort="Ferreira, Alberto" uniqKey="Ferreira A" first="Alberto" last="Ferreira">Alberto Ferreira</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002704 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002704 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26327116
|texte= Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26327116" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |